3 Under the Radar Dividend Aristocrats to Bank On

Wednesday, September 15, 2021 | Sean Sechler
3 Under the Radar Dividend Aristocrats to Bank OnWhenever the stock market falters and goes through a period of weakness like we have seen thus far in September, there are two things that investors should do. First, they should reflect on the companies that they own and decide whether or not to reduce their exposure to underperformers that might really drag their portfolio down if the market indeed heads into a corrective phase. After that, investors should create a plan of attack that allows them to capitalize on high-quality companies that become more attractive as their prices go down.

While it’s not easy to make new buys when the market feels weak, adding shares of dividend aristocrats makes clicking the buy button a lot simpler. That’s because they are companies with durable competitive advantages and a history of raising their dividends for at least 25 consecutive years, so investors know they are buying quality. What’s even more intriguing is that as the share prices of dividend aristocrats decline, their dividend yields go up. 

A curious case with dividend aristocrats is that although they are an elite group of companies, many of them don't receive a lot of exposure in financial media. That changes now as we highlight 3 under the radar dividend aristocrats to bank on below. 

Archer-Daniels-Midland (NYSE: ADM)

Consumer staples are usually a good place to park some cash when volatility is rising, and Archer Daniels Midland is one of the best businesses in the sector that you’ve probably never heard of. The company is one of the world’s leading producers of food and beverage ingredients, along with other agricultural commodities. With products including natural flavors and colors, vegetable oils, health and nutrition products, animal feed, and biofuels, Archer Daniels Midland plays a huge role in keeping the world fed, which is certainly something that investors can bank on for the long term since people will always need to eat.

There’s also some long-term upside to consider given that this company is a major producer of soybeans, which means it might take advantage of increasing demand for renewable green diesel and plant-based food. Archer Daniels Midland recently delivered record Q2 EPS of $1.26 and is poised for a strong finish to its fiscal year, making it another solid pick among dividend aristocrats. Finally, with a dividend yield of 2.42% and 47 consecutive years of dividend growth, this is exactly the type of stock that investors should look at for a combination of stable earnings and passive income.

Linde plc (NYSE: LIN)

Next, we have a leading industrial gases and engineering company that manufactures and distributes its products to a diverse customer base including industries like health care, petroleum refining, steel making, aerospace, chemicals, manufacturing, and more. If you aren’t familiar with industrial gases, they include atmospheric gases like oxygen, nitrogen, and argon along with process gases like hydrogen, carbon dioxide, and helium. These gases are truly essential for industrial production around the world, and Linde is very attractive given that most customers sign up for long-term contracts that deliver stable cash flows.

If you think that industrial production is going to rise as the impacts of the pandemic subside, it's hard to argue against owning shares of Linde at this time since the demand for industrial gases should soar as the world’s economy recovers. There’s also a lot to like about the company’s recent merger with Praxair, which helped Linder become the largest industrial gas company in the world and should lead to synergies in the long term. The stock currently offers investors a 1.35% dividend yield and the company has raised its dividend for 28 consecutive years, making it a great buy-the-dip dividend aristocrat to consider if the market weakness persists. 

West Pharmaceutical Services, Inc. (NYSE: WST)

The recurring theme with these under-the-radar dividend aristocrats is that although they might not be the most exciting companies in the world, each one is a global market leader in its respective industry that produces products or services which see steady demand in almost any economic environment. This is the case with West Pharmaceutical Services, which is a global manufacturer in the design and production of containment and delivery systems for drugs and health care products.

Think about how important basic medical equipment like syringes, stoppers, and plungers are in the healthcare industry, particularly following the pandemic. The company’s leading market share in injectable primary packaging means that its sales are benefitting from the Covid-19 outbreak, especially since diagnostics and vaccines are likely going to see boosted demand for many years to come. West Pharmaceutical Services has increased its dividend for 28 consecutive years and is a worthwhile pick for any investor looking to add healthcare stocks.

Should you invest $1,000 in West Pharmaceutical Services right now?

Before you consider West Pharmaceutical Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and West Pharmaceutical Services wasn't on the list.

While West Pharmaceutical Services currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here

 


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
West Pharmaceutical Services (WST)2.0$454.47+0.4%0.15%66.44Buy$387.50
Linde (LIN)2.5$313.08-0.5%1.35%50.25Buy$335.45
Archer-Daniels-Midland (ADM)2.8$63.00+0.8%2.35%15.37Buy$65.30
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.